Stay updated on Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added related topics: Multiple Myeloma and MedlinePlus Genetics on the study page to help users find related information. No trial data or eligibility criteria were altered.
    Difference
    0.2%
    Check dated 2026-01-01T00:00:48.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The core condition label 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics' were removed from the page.
    Difference
    0.2%
    Check dated 2025-12-24T23:28:57.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a Locations section with New Jersey and New York sites and updated the page revision to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-17T19:52:32.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added related topics: Multiple Myeloma and the MedlinePlus Genetics link on the study page. These are supplementary contextual links and do not change the core study details.
    Difference
    0.2%
    Check dated 2025-12-03T16:47:51.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and 'Multiple myeloma' along with the related topic 'MedlinePlus Genetics' were removed from the page topics.
    Difference
    0.2%
    Check dated 2025-11-26T13:59:28.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added related topics 'Multiple myeloma' and 'MedlinePlus Genetics' to the study page to provide disease context and references. Removed the government funding status notice that previously informed users about operating status and updates.
    Difference
    0.5%
    Check dated 2025-11-19T08:39:56.000Z thumbnail image

Stay in the know with updates to Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.